Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?

The outcome and quality of life of chronic myeloid leukemia (CML) patients has remarkably changed with the treatment of tyrosine kinase inhibitors (TKIs). Currently, hematopoietic stem cell transplantation (HSCT) is considered mainly as a third line salvage therapy in cases of TKIs resistance or int...

Descripción completa

Detalles Bibliográficos

Autores principales:	Avital F. Barak, Lilach Bonstein, Roy Lauterbach, Elizabeth Naparstek, Sigal Tavor
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2011-12-01
Colección:	Hematology Reports
Materias:	chronic myeloid leukemia, tyrosine kinase inhibitor, thrombocytopenia, HSCT
Acceso en línea:	http://www.pagepress.org/journals/index.php/hr/article/view/3322
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!